Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OFATUMUMAB vs RITUXIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OFATUMUMAB vs RITUXIMAB: Safety Overview

Metric OFATUMUMAB RITUXIMAB
Total FAERS Reports 29,913 178,614
Deaths Reported 695 28,910
Death Rate 2.3% 16.2%
Hospitalizations 3,616 54,631
Average Patient Age 47.5 yrs 54.6 yrs
% Female Patients 74.9% 64.3%
Manufacturer Novartis Pharmaceuticals Corporation Genentech, Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Prescription